Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial

Table 1 Respondent Characteristics

VARIABLE	PARTICIPANTS (n = 26)
Age
20–29	3
30–39	11
40–49	6
50–59	3
60–69	3
Gender
Women	19
Men	6
Transgender	1
Education^a
Some college	1
Technical/associate degree	2
Bachelor	2
Master	8
PhD	5
MD	10
Study role
Site PI	4
Study clinician	7
Study coordinator	8
Research assistant	5
Outreach worker	1
QA monitor	1
Years at clinic
1–3	8
4–6	5
7–9	2
10–12	3
13–16	5
17–19	0
20+	3
Years experience with HIV or SUD
1–3	4
4–6	6
7–9	2
10–12	2
13–16	6
17–19	2
20+	4
Years experience with MOUD
1–3	15
4–6	4
7–9	1
10–12	3
13–16	2
17–19	0
20+	1

^aNumbers will equal more than 26 as some participants reported more than 1 degree
MOUD Medications for opioid use disorder treatment (e.g. naltrexone, buprenorphine, and methadone)

ISSN: 1472-6963